arrow
B

Bernhard Zimmermann

natera, inc
H指数:38
被引数:9,671

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A two-threshold algorithm using donor-derived cell-free DNA fraction and quantity to detect acute rejection after heart transplantation

一种基于供者来源游离DNA分数和含量的双阈值算法,用于检测心脏移植后的急性排斥反应

2025-05-050
OAAI
Correlation between variant allele frequency and mean tumor molecules with tumor burden in patients with solid tumors
2023-12-235
OA
Combining Donor-derived Cell-free DNA Fraction and Quantity to Detect Kidney Transplant Rejection Using Molecular Diagnoses and Histology as Confirmation
2022-11-2231
OAAI
Circulating tumor DNA in neoadjuvant-treated breast cancer reflects response and survival

新辅助治疗乳腺癌的循环肿瘤DNA反映了疗效和生存率

2021-02-01242
OAAI
Personalized circulating tumor DNA analysis as a predictive biomarker in solid tumor patients treated with pembrolizumab
2020-08-03295
PREAI
Personalized monitoring of circulating tumor DNA during neoadjuvant therapy in high-risk early stage breast cancer reflects response and risk of metastatic recurrence
2020-02-151
PRE
Personalized Detection of Circulating Tumor DNA Antedates Breast Cancer Metastatic Recurrence

个性化检测循环肿瘤DNA预测乳腺癌转移复发

2019-07-15310
OAAI
Early detection of metastatic relapse and monitoring of therapeutic efficacy by ultra-deep sequencing of plasma cell-free DNA in patients with urothelial bladder carcinoma
2019-07-015
PRE
Optimizing Detection of Kidney Transplant Injury by Assessment of Donor-Derived Cell-Free DNA via Massively Multiplex PCR
2018-12-23176
OAAI